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Abstract In eukaryotes, transcriptional regulation upon stimu-
lation of the adenylyl cyclase signalling pathway is mediated by a 
family of cAMP-responsive nuclear factors. This family consists 
of a large number of members which may act as activators or 
repressors. These factors contain the basic domain/leucine zipper 
motifs and bind as dimers to cAMP-response elements (CRE). 
The function of CRE-binding proteins (CREB) is modulated by 
phosphorylation by the cAMP-dependent protein kinase. The 
ICER (inducible cAMP early repressor) protein is the only 
inducible member of this family and is a product of the CREM 
gene. The induction of this powerful repressor is likely to be 
important for the transient nature of cAMP-induced gene 
expression. CREB proteins have been found to play an important 
role in the physiology of neuroendocrine functions. In addition, 
recent results indicate that CREB and CREM could be involved 
in the proliferation of hepatocytes which follows partial 
hepatectomy. 
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1. Coupling cAMP signalling to gene expression 
The function of transcription factors is modulated by spe-
cific signal transduction pathways which are activated intra-
cellularly by various signals at the cell surface. Intracellular 
levels of cAMP are regulated primarily by adenylyl cyclase. 
This enzyme is in turn modulated by various extracellular 
stimuli mediated by receptors and their interaction with G-
proteins. The binding of a specific ligand to a receptor results 
in the activation or inhibition of the cAMP-dependent path-
way, ultimately affecting the transcriptional regulation of var-
ious genes through distinct promoter responsive sites [1]. In-
creased cAMP levels directly affect the function of the 
tetrameric protein kinase A (PKA) complex. Binding of 
cAMP to two PKA regulatory subunits releases the catalytic 
subunits enabling them to phosphorylate target proteins. An 
important fraction of the catalytic subunit molecules migrates 
into the nucleus (Fig. 1). A number of isoforms for both the 
regulatory and catalytic subunits have been identified suggest-
ing a further level of complexity in this response. In the nu-
cleus, the phosphorylation state of transcription factors and 
related proteins appears to directly modulate their function 
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and thus the expression of cAMP-inducible genes (Fig. 1). 
The analysis of promoter sequences of several genes allowed 
the identification of promoter elements which could mediate 
the transcriptional response to increased levels of intracellular 
cAMP [2]. A number of sequences have been identified of 
which the best characterised is the cAMP-responsive element 
(CRE). The CRE is constituted by an 8 bp palindromic se-
quence (TGACGTCA). Several genes which are regulated by 
a variety of endocrinological stimuli contain CREs in their 
promoter regions [1,2]. 
2. cAMP and cellular proliferation: the liver as model system 
In the liver, the cAMP-responsive signalling pathway plays 
an important role in gene regulation. Indeed, it has been 
shown that modulation of liver-specific gene expression is 
correlated with increases of cAMP levels [3], modulated ex-
pression of G-protein subunits, adenylyl cyclase [4] or PKA 
[5]. Yet, the involvement of cAMP-responsive transcription 
factors in liver function is poorly understood. A role for 
CREB phosphorylation in the regulation of liver gene expres-
sion has been postulated [6]. 
The liver provides a remarkable system to study the phe-
nomenon of cellular proliferation in vivo and thus to analyze 
the involvement of specific events in gene regulation. In this 
respect the paradigm of the partial hepatectomy (PH) consti-
tutes an invaluable tool. Indeed, PH triggers coordinated hep-
atocyte proliferation which ensures complete reconstitution of 
the liver mass [7-10]. This process has been used extensively as 
a model system to study mechanisms regulating cell growth 
and proliferation. Importantly, a multitude of signalling path-
ways are activated during liver regeneration [3,9]. During the 
first hours following partial hepatectomy, glucocorticoids are 
involved in the regulation of gene expression. In addition, it 
has been shown that glucagon and adrenalin direct an in-
crease in intracellular cAMP levels during the first 2-6 h 
[4,11]. A second peak of cAMP occurs before the first round 
of mitosis [4,12]. Various studies have documented associated 
changes in the expression of PKA subunits [5] and have 
strongly implicated cAMP in the regulation of hepatocyte 
proliferation [13]. Importantly, recent results indicate that 
treatment of hepatoma cells in vitro with cAMP results in a 
powerful CREB phosphorylation and in an increase of ICER 
levels [14]. These findings implicate the CREM gene as a ma-
jor player in the cAMP-regulated response of hepatocytes [14]. 
Thus, in addition to modulating gene expression in response 
to hormonal stimuli in differentiated cells, these transcription 
factors have a role in the proliferative events linked to liver 
regeneration after partial hepatectomy (Fig. 1). 
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Fig. 1. The cAMP signal transduction pathway. Schematic representation of the route whereby ligands at the cell surface interact with mem-
brane receptors (R) and thereby result in altered gene expression. Ligand binding activates coupled G-proteins (G) which in turn stimulates the 
activity of the membrane-associated adenylyl cyclase (AC). This converts ATP to cAMP which causes the dissociation of the inactive tetrameric 
protein kinase A (PKA) complex into the active catalytic subunits (C) and the regulatory subunits (R). Catalytic subunits migrate into the nu-
cleus where they phosphorylate (P) and thereby activate transcriptional activators such as CREB and CREMx. These then interact with the 
cAMP response enhancer element (CRE) found in the promoters of cAMP-responsive genes to activate transcription. The products of these 
genes influence the hormonal response, differentiation and proliferation. In particular, the activation of CREB and ICER in hepatocytes upon 
partial hepatectomy could be an important event regulating cellular proliferation. 
3. CREB and CREM regulation in hepatocytes 
Very little is known with respect to the nuclear effectors of 
the cAMP pathway in hepatocyte proliferation and function 
in the liver. As mentioned, recent results document dynamic 
expression of CRE-binding factors in liver and cultured hep-
atoma cells [14]. Indeed, both CREB phosphorylation and 
ICER [15,16] expression are powerfully induced following 
partial hepatectomy. In this model system, an increase in 
cAMP follows hepatectomy in response to hormonal and pro-
liferative stimulation. This induction is known to be biphasic. 
The first peak occurs 2-6 h after partial hepatectomy, while 
the second peak, which precedes DNA synthesis, occurs 10-16 
h after partial hepatectomy [4,12]. ICER inducibility coincides 
with the first peak [14]. 
In vitro studies with primary hepatocytes have demon-
strated that transient cAMP induction increases DNA synthe-
sis in the presence of epidermal growth factor (EGF), while 
constant cAMP treatment inhibits DNA synthesis [4,17]. 
Therefore, we speculate that the first peak of cAMP, and 
thus the associated increase in ICER expression, is linked 
with the transient upregulation of genes that are expressed 
in Gl phase (e.g. c-fos; [18]), during the first hours following 
hepatectomy. The second peak of cAMP may be more specif-
ically linked to the regulation of DNA synthesis. Indeed, this 
scenario would be in agreement with observations by MacMa-
nus et al. [12] who have demonstrated that pharmacological 
inhibition of the first cAMP peak does not affect DNA syn-
thesis, while delay of the second peak is sufficient to retard 
DNA synthesis [12]. 
4. Conclusions and perspectives 
CREB phosphorylation and the consequent induction of 
the ICER repressor in the liver beg the question of which 
genes may be under the control of these transcription factors. 
Several hepatocyte-specific genes have been postulated to be 
regulated by the cAMP-responsive signalling pathway [3]. 
Thus, these results constitute a first step in the elucidation 
of the mechanisms involved in the regulation of these genes. 
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I C E R induction during liver regeneration deserves special 
attention. Indeed, this event links, for the first time, the in-
ducibility of the repressor ICER to a proliferative process 
(Fig. 1). The markedly transient induction of I C E R protein 
following P H [14], which differs from that observed in other 
systems [19,20], may suggest a distinct function. The involve-
ment of CREM gene products in the regulation of cyclin A 
gene and possibly of the cell cycle has been also forwarded 
[21]. In addition, ablation of the CREM gene in the mouse 
germline by homologous recombination results in an arrest of 
post-meiotic male germ cell differentiation and an increase in 
apoptosis [22]. These observations support the notion that the 
CREM gene may have a key role in the differentiation/pro-
liferation decision made by certain cell types in response to 
activation of specific signalling pathways. The analysis of the 
physiological and molecular events following P H in the 
CREM-deficient mice should be then of interest and is likely 
to shed new light on the multifaceted functions of this tran-
scription factor. 
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